Results 151 to 160 of about 29,066 (192)

Effects of malnutrition on disease severity and adverse outcomes in idiopathic pulmonary arterial hypertension: a retrospective cohort study. [PDF]

Respir Res
Zhang S, Li S, Gao L, Zhao Q, Yang T, Zeng Q, Huang Z, Li X, Duan A, Wang Y, Zhao Z, Luo Q, Liu Z.   +12 more
europepmc   +1 more source

Serum PM20D1 levels in patients with idiopathic pulmonary arterial hypertension and its clinical significance. [PDF]

BMC Cardiovasc Disord
Wang L, Liu J, Zhou L, Fu Q.
europepmc   +1 more source

Loss of pulmonary capillaries in idiopathic pulmonary arterial hypertension with low diffusion capacity is accompanied by early diffuse emphysema detected by ¹²⁹Xe MRI. [PDF]

Eur Radiol
Kern AL, Park DH, Fuge J, Hohlfeld JM, Wacker F, Hoeper MM, Olsson KM, Vogel-Claussen J.   +7 more
europepmc   +1 more source

Identification of potential biomarkers for idiopathic pulmonary arterial hypertension using single-cell and bulk RNA sequencing analysis. [PDF]

Front Genet
Du Y, Zhang J, Guo K, Yin Y.
europepmc   +1 more source

Is pulmonary vascular remodeling an intermediate link between hyperglycemia and adverse outcomes in patients with idiopathic pulmonary arterial hypertension? Insights from a multi-center cohort study. [PDF]

Cardiovasc Diabetol
Zhang S, Gao L, Li S, Luo M, Xi Q, Lin P, Zhao Z, Zhao Q, Yang T, Zeng Q, Huang Z, Li X, Duan A, Wang Y, Luo Q, Guo Y, Liu Z.   +16 more
europepmc   +1 more source

[Arterial pulmonary hypertension: secondary or idiopathic?].

Medicina, 1980
openaire   +1 more source

Phenotypes of idiopathic pulmonary arterial hypertension [PDF]

The Lancet Respiratory Medicine, 2022
info:eu-repo/semantics ...
Alejandro, Cruz-Utrilla, Carmen, Pérez-Olivares, Amaya, Martínez-Meñaca, Manuel, López-Meseguer, Pilar, Escribano-Subias   +4 more
  +7 more sources

Asymmetrical Dimethylarginine in Idiopathic Pulmonary Arterial Hypertension [PDF]

Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
Objective— We explored the potential role of the endogenous NO synthase inhibitor asymmetrical dimethylarginine (ADMA) in patients with idiopathic pulmonary arterial hypertension (IPAH). Method and Results— We correlated plasma
Jan T Kielstein, Marius M Hoeper, Jens Martens-Lobenhoffer   +2 more
exaly   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Iloprost for idiopathic pulmonary arterial hypertension

Expert Review of Cardiovascular Therapy, 2005
Idiopathic pulmonary arterial hypertension is a rare but serious and life-threatening disease that leads to right heart failure and death within 2.8 years without specific treatment. This review focuses on the stable prostacyclin analog iloprost, its biologic action and pharmacology and, finally, on its clinical development, efficacy and safety in ...
Juergen Behr, Hanno H Leuchte
exaly   +3 more sources

Idiopathic Pulmonary Arterial Hypertension

Seminars in Respiratory and Critical Care Medicine, 2013
Idiopathic pulmonary arterial hypertension (IPAH), formerly called primary pulmonary hypertension, is a rare disease (incidence and prevalence rates of approximately one and six cases per million inhabitants, respectively) with different clinical phenotypes.
Rogerio, Souza, Carlos, Jardim, Marc, Humbert   +2 more
openaire   +2 more sources